AI Models for Protein Design are Driving Antibody Engineering

Area of Science:

• Biotechnology
• Computational Biology
• Immunology

Background:

• Therapeutic antibody engineering aims to develop antibodies with precise target binding and optimal drug characteristics.
• Deep learning (DL) methods enhance antibody generation by integrating existing knowledge and experimental data.
• Advances in predicting protein structures, including antibodies and antigens, are crucial for this field.

Purpose of the Study:

• To review the integration of deep learning-based protein structure prediction and design in antibody therapeutics.
• To highlight the impact of structure-based generative models in antibody engineering.

Main Methods:

• Leveraging advancements in deep learning for protein structure prediction.
• Utilizing predicted structures of antibodies and target antigens.
• Applying structure-based generative models for antibody design.

Main Results:

• Emergence of powerful structure-based generative models for antibody design.
• Improved antibody generation methods guided by deep learning.

Conclusions:

• Deep learning-based structure prediction and design are transforming antibody therapeutics.
• The synergy between DL and structural biology accelerates the development of novel antibody-based drugs.